Method Study: Bilateral TAP Block With 24 Hours Infusion

Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT01577940
Collaborator
(none)
8
2
2
16
4
0.3

Study Details

Study Description

Brief Summary

The purpose of this method study in healthy volunteers is to determine the extent of sensory block following Transversus Abdominis Plane (TAP) block with 24 hours infusion of ropivacaine versus infusion of saline. Furthermore, to determined the analgesic effect of the TAP block and the influence on the lung function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Infusion of ropivacaine
  • Procedure: Infusion of saline
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Method Study of Bilateral Transversus Abdominis Plane (TAP) Block With 24 Hours Infusion. Extent of Sensory Block, Analgetic Effect and Lung Function in Healthy Volunteers
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
May 1, 2012
Actual Study Completion Date :
May 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Infusion of local anesthetic

TAP block with 20 ml of ropivacaine 0,5%, catheter with infusion of ropivacaine 0,2% 5 ml/h 24 hours.

Procedure: Infusion of ropivacaine
TAP block with ropivacaine 20 ml 0,5%. Catheter with infusion of ropivacaine 0,2% 5 ml/h 24 hours on one side of the abdomen.

Placebo Comparator: Infusion of saline

TAP block with 20 ml of ropivacaine 0,5%, catheter with infusion of saline 5 ml/h 24 hours.

Procedure: Infusion of saline
TAP block with ropivacaine 0,5% 20 ml. Catheter with infusion of saline 5 ml/h 24 hours.

Outcome Measures

Primary Outcome Measures

  1. Change in extend of sensory block from baseline (pre block) to 24 hours post block, based on 6 measurements [-15 min., 1, 4, 8, 12 and 24 hours following TAP block]

    Extent of sensory block using pinprick and ice

Secondary Outcome Measures

  1. Heat pain detection threshold (abdomen) [-15 min., 1, 4, 8, 12 and 24 hours following TAP block]

    Gradually heating of the skin from 32 to 52 degrees Celcius. The participant indicates the temperature where the stimulus is painful.

  2. Heat pain detection threshold (dominant forearm) [-15 min., 1, 4, 8, 12 and 24 hours following TAP block]

    Gradually heating of the skin from 32 to 52 degrees Celcius. The participant indicates the temperature where the stimulus is painful.

  3. Long Thermal stimulation (abdomen) [-15 min., 1, 4, 8, 12 and 24 hours following TAP block]

    Heating of the skin, 45 degrees Celsius 1 minute. The participant indicates pain scores on a Visuel Analog Scale from 0 (no pain) to 100 (worst imaginable)

  4. Lung function [-15 min., 1, 4, 8, 12 and 24 hours following TAP block]

    Inspiratory and expiratory force

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age between 18 and 30 years

  • written consent

  • ASA 1

  • BMI between 18 and 25

  • males

Exclusion Criteria:
  • unable to communicate in Danish

  • relevant drug allergy

  • alcohol or/and drug abuse

  • daily intake of prescription pain medication the last 4 weeks

  • pain medication in the last 48 hours

  • previously operated abdominal

Contacts and Locations

Locations

Site City State Country Postal Code
1 HOC, anesthesiology, Rigshospitalet Copenhagen Denmark 2100
2 HovedOrtoCentret, Rigshospitalet Copenhagen Denmark 2100

Sponsors and Collaborators

  • Glostrup University Hospital, Copenhagen

Investigators

  • Principal Investigator: Pernille L Petersen, MD, HOC, anesthesiology, Rigshospitalet, Copenhagen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pernille Lykke Petersen, Principal investigator, Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT01577940
Other Study ID Numbers:
  • SM1-PLP-11
  • 2011-005118-13
First Posted:
Apr 16, 2012
Last Update Posted:
May 4, 2012
Last Verified:
May 1, 2012
Keywords provided by Pernille Lykke Petersen, Principal investigator, Glostrup University Hospital, Copenhagen
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2012